The effect of surgery on the outcome of treatment for multidrug-resistant tuberculosis: A systematic review and meta-analysis

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Harris, Rebecca C ^a   Khan, Mishal S ^a,b   Martin, Laura J ^c   Allen, Victoria ^d   Moore, David A J ^a   Fielding, Katherine ^a,e   Grandjean, Louis ^f   Amini, Ali ^a   Buchanan, Ruaridh ^g   Krutikov, Maria ^h  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^d CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g BARTS HEALTH NHS TRUST   (United Kingdom)

^h UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Extensively drug resistant; Meta analysis; Multi drug resistant; Pneumonectomy; Surgery; Systematic review; Tuberculosis

Indexed keywords

ARTICLE; CAUSE OF DEATH; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; LUNG LOBECTOMY; LUNG RESECTION; LUNG SURGERY; META ANALYSIS; MULTIDRUG RESISTANT TUBERCULOSIS; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT FAILURE; ODDS RATIO; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

TUBERCULOSTATIC AGENT;

ANTITUBERCULAR AGENTS; HUMANS; ODDS RATIO; PNEUMONECTOMY; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84973547969     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1585-0     Document Type: Article

References (43)

1. World Health Organization Global tuberculosis report http://www.who.int/tb/publications/global_report/en/. Accessed: 3 Oct 2015.
2. U.S. Food and Drug Administration Press Announcements - FDA approves first drug to treat multi-drug resistant tuberculosis http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333695.htm Accessed: 30 Nov 2015
3. Deoghare S. Bedaquiline: a new drug approved for treatment of multidrug-resistant tuberculosis. Indian J Pharmacol. 2013;45(5):536-7.
4. World Health Organization. The use of delamanid in the treatment of multidrug-resistant tuberculosis. 2014 http://www.who.int/tb/publications/delamanid-in-mdr-tb-treatment/en/. Accessed: 30 Nov 2015
5. World Health Organization. Interim guidance on the use of bedaquiline to treat MDR-TB. 2013 http://www.who.int/tb/challenges/mdr/bedaquiline/en/. Accessed: 30 Nov 2015.
6. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis, emergency update. 2008 http://apps.who.int/iris/bitstream/10665/43965/1/9789241547581_eng.pdf. Accessed: 5 Oct 2015.
7. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis, 2011 update. 2011 http://apps.who.int/iris/bitstream/10665/44597/1/9789241501583_eng.pdf. Accessed: 5 Oct 2015.
8. Iseman MD, Madsen L, Goble M, Pomerantz M. Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis. Am Rev Respir Dis. 1990;141:623-5.
9. Kempker RR, Vashakidze S, Solomonia N, Dzidzikashvili N, Blumberg HM. Surgical treatment of drug-resistant tuberculosis. Lancet Infect Dis. 2012;12:157-66.
10. Marrone MT, Venkataramanan V, Goodman M, Hill AC, Jereb JA, Mase SR. Surgical interventions for drug-resistant tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2013;17:6-16.
11. Harris R, Fielding K, Khan M, Grandjean L, Martin L, Moore D. The effect of surgery on the outcomes of MDRTB treatment. PROSPERO 2015:CRD42015029501. In: PROSPERO International prospective register of systematic reviews http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015029501. Accessed: 30 Nov 2015.
12. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-9. W264.
13. University of York. Systematic Reviews, CRD's guidance for undertaking reviews in health care https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf Accessed: 7 Mar 2016
14. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Accessed: 4 Sep 2015.
15. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377-84.
16. West S, King V, Carey TS, Lohr KN, McKoy N, Sutton SF, Lux L. Systems to rate the strength of scientific evidence. In: AHRQ Evidence Report Summaries Rockville (MD) : Agency for Healthcare Research and Quality (US); 1998-2005. 2002.
17. Higgins JPT: Green S. Cochrane handbook for systematic reviews of interventions version 5.1. 0. The Cochrane Collaboration 2011, 5(0).
18. World Health Organization. Treatment of Tuberculosis: guidelines for national programmes. 2009 http://www.who.int/tb/publications/cds_tb_2003_313/en/. Accessed 5 Oct 2015.
19. Grading of Recommendations, Assessment, Development and Evaluation (GRADE) Working Group. GRADE handbook. 2013 http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html. Accessed: 30 Oct 2015.
20. Falzon D, Gandhi N, Migliori GB, Sotgiu G, Cox HS, Holtz TH, Hollm-Delgado MG, Keshavjee S, DeRiemer K, Centis R, et al. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J. 2013;42(1):156-68.
21. Fox GJ, Mitnick CD, Benedetti A, Chan ED, Becerra M, Chiang CY, Keshavjee S, Koh WJ, Shiraishi Y, Viiklepp P, et al. Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis. Clin Inf Dis. 2016;62:887-95.
22. Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, et al. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis. 2008;47:496-502.
23. Leimane V, Riekstina V, Holtz TH, Zarovska E, Skripconoka V, Thorpe LE, Laserson KF, Wells CD. Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet. 2005;365:318-26.
24. Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, Fitzmaurice GM, Alcantara Viru FA, Appleton SC, Bayona JN, et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Eng J Med. 2008;359:563-74.
25. Törün T, Tahaoğlu K, Ozmen I, Sevim T, Ataç G, Kir A, Güngör G, Bölükbaşi Y, Maden E. The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2007;11(9):979-85.
26. Dravniece G, Cain KP, Holtz TH, Riekstina V, Leimane V, Zaleskis R. Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis. Eur Respir J. 2009;34(1):180-3.
27. Sklyuev S, Levin A, Tcheimach E, Krasnov D. PC-658-02 Complex treatment approach for patients with destructive pulmonary tuberculosis by application of endobronchial valve. Int J Tuberc Lung Dis. 2013; 17(12, Supp.2):S329-330.
28. Tahaoğlu K, Törün T, Sevim T, Ataç G, Kir A, Karasulu L, Ozmen I, Kapakli N. The treatment of multidrug-resistant tuberculosis in Turkey. N Engl J Med. 2001;345:170-4.
29. Shean KP, Willcox PA, Siwendu SN, Laserson KF, Gross L, Kammerer S, Wells CD, Holtz TH. Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992-2002. Int J Tuberc Lung Dis. 2008;12(10):1182-9.
30. Kwak N, Kim HR, Yoo CG, Kim YW, Han SK, Yim JJ. Changes in treatment outcomes of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2015;19:525-30.
31. Kim H-R, Hwang SS, Kim HJ, Lee SM, Yoo C-G, Kim YW, Han SK, Shim Y-S, Yim J-J. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Clin Infect Dis. 2007;45(10):1290-5.
32. Kim DH, Kim HJ, Park S-K, Kong S-J, Kim YS, Kim T-H, Kim EK, Lee KM, Lee SS, Park JS, et al. Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. Am J Respir Crit Care Med. 2008;178:1075-82.
33. Keshavjee S, Gelmanova IY, Farmer PE, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD, Atwood S, Mukherjee JS, Rich ML, et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet. 2008;372:1403-9.
34. Karagöz T, Yazicioğlu Moçin O, Pazarli P, Senol T, Yeti Duman D, Duman G, Saltürk C, Unal O, Halezeroğlu S. The treatment results of patients with multidrug resistant tuberculosis and factors affecting treatment outcome. Tuberk Toraks. 2009;57:383-92.
35. Gegia M, Kalandadze I, Kempker RR, Magee MJ, Blumberg HM. Adjunctive surgery improves treatment outcomes among patients with multidrug-resistant and extensively drug-resistant tuberculosis. Int J Infect Dis. 2012;16:e391-6.
36. Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R, et al. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012;9(8):e1001300.
37. Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One. 2009;4:e6914.
38. Park SK, Lee WC, Lee DH, Mitnick CD, Han L, Seung KJ. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea. Int J Tuberc Lung Dis. 2004;8(3):361-8.
39. Burgos M, Gonzalez LC, Paz EA, Gournis E, Kawamura LM, Schecter G, Hopewell PC, Daley CL. Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient-based approach. Clin Infect Dis. 2005;40(7):968-75.
40. Escudero E, Pena JM, Alvarez-Sala R, Vazquez JJ, Ortega A. Multidrug-resistant tuberculosis without HIV infection: success with individualised therapy. Int J Tuberc Lung Dis. 2006;10(4):409-14.
41. Roberts I, Ker K. How systematic reviews cause research waste. Lancet. 2015;386(10003):1536.
42. Naidoo R. Surgery for pulmonary tuberculosis. Curr Opin Pulm Med. 2008;14(3):254-9.
43. Wu S, Zhang Y, Sun F, Chen M, Zhou L, Wang N, et al. Adverse events associated with the treatment of multidrug-resistant tuberculosis: a systematic review and meta-analysis. Am J Ther. 2013.